ConductScience.org, home

Paper20200325

Tegaserod and the risk of cardiovascular ischemic events: an observational cohort study.

Loughlin J and 7 others. J Cardiovasc Pharmacol Ther, 2010. Cited by 59 papers, by iCite.

Cite this record

ConductScience Library. Tegaserod and the risk of cardiovascular ischemic events: an observational cohort study. Papers, record 20200325. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20200325

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Tegaserod and the risk of cardiovascular ischemic events: an observational cohort study.
PubMed
Journal
J Cardiovasc Pharmacol Ther
PubMed
Year
2010
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
59
iCite
Relative citation ratio, by iCite
2.1
iCite
Revised in PubMed
2022-04-10
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Loughlin JJeanne
2Quinn SSherry
3Rivero EElena
4Wong JJudy
5Huang JJiaquing
6Kralstein JJeffrey
7Earnest DLDavid L
8Seeger JDJohn D

Source PubMed

Download CSV of authors

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Gastrointestinal AgentsMajor topic
IndolesMajor topic
Myocardial IschemiaMajor topic
StrokeMajor topic
Adolescent
Adult
Age Factors
Aged
Child
Child, Preschool
Cohort Studies
Female
Humans
Infant
Insurance Claim Review
Male
Middle Aged
Sex Factors
Young Adult

Source PubMed

Download CSV of topics

Cited by34

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 59 citations.

PMIDTitleJournalYearIn PapersSource
37762575Small Organic Compounds Mimicking the Effector Domain of Myristoylated Alanine-Rich C-Kinase Substrate Stimulate Female-Specific Neurite Outgrowth.Int J Mol Sci2023https://conductscience.org/library/papers/37762575PubMed
35207632Gastrointestinal Dysfunction in Parkinson's Disease: Current and Potential Therapeutics.J Pers Med2022https://conductscience.org/library/papers/35207632PubMed
34683919Active Targeted Nanoemulsions for Repurposing of Tegaserod in Alzheimer's Disease Treatment.Pharmaceutics2021https://conductscience.org/library/papers/34683919PubMed
34047303Tegaserod for Irritable Bowel Syndrome With Constipation in Women Younger Than 65 Years Without Cardiovascular Disease: Pooled Analyses of 4 Controlled Trials.Am J Gastroenterol2021https://conductscience.org/library/papers/34047303PubMed
32691294Functional Dyspepsia: Diagnostic and Therapeutic Approaches.Drugs2020https://conductscience.org/library/papers/32691294PubMed
32085796Repurposing the serotonin agonist Tegaserod as an anticancer agent in melanoma: molecular mechanisms and clinical implications.J Exp Clin Cancer Res2020https://conductscience.org/library/papers/32085796PubMed
31897312Pharmacological Approaches to Diabetic Gastroparesis: A systematic review of randomised clinical trials.Sultan Qaboos Univ Med J2019https://conductscience.org/library/papers/31897312PubMed
31485565Opioid-Induced Hypogonadism in the United States.Mayo Clin Proc Innov Qual Outcomes2019https://conductscience.org/library/papers/31485565PubMed
30522596Management Options for Irritable Bowel Syndrome.Mayo Clin Proc2018https://conductscience.org/library/papers/30522596PubMed
30205698Testosterone replacement therapy and hospitalization rates in men with COPD.Chron Respir Dis2019https://conductscience.org/library/papers/30205698PubMed
29930260New treatments and therapeutic targets for IBS and other functional bowel disorders.Nat Rev Gastroenterol Hepatol2018https://conductscience.org/library/papers/29930260PubMed
29147138An update on prucalopride in the treatment of chronic constipation.Ther Adv Gastroenterol2017https://conductscience.org/library/papers/29147138PubMed
28928800Weikangning therapy in functional dyspepsia and the protective role of Nrf2.Exp Ther Med2017https://conductscience.org/library/papers/28928800PubMed
27371355Statin use and uterine fibroid risk in hyperlipidemia patients: a nested case-control study.Am J Obstet Gynecol2016https://conductscience.org/library/papers/27371355PubMed
27325124Hypogonadism and the risk of rheumatic autoimmune disease.Clin Rheumatol2016https://conductscience.org/library/papers/27325124PubMed
27313955Use of Serotonergic Drugs in Canada for Gastrointestinal Motility Disorders: Results of a Retrospective Cohort Study.Scientifica (Cairo)2016https://conductscience.org/library/papers/27313955PubMed
27099579Treatment of Chronic Constipation: Prescription Medications and Surgical Therapies.Gastroenterol Hepatol (N Y)2015https://conductscience.org/library/papers/27099579PubMed
26576134Recent Updates on the Treatment of Constipation.Intest Res2015https://conductscience.org/library/papers/26576134PubMed
25953004Patterns of Lipid Lowering Therapy among Children Ages 8-20 Years.J Pediatr2015https://conductscience.org/library/papers/25953004PubMed
25729103Screening and monitoring in men prescribed testosterone therapy in the U.S., 2001-2010.Public Health Rep2015https://conductscience.org/library/papers/25729103PubMed

See all 34 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/20200325

GET https://conductscience.org/api/papers/v1/20200325/cited_by?page=2